Zimmer Biomet awarded $13.3M in patent spat with Stryker subsidiary — 3 things to know

Shayna Korol -   Print  |

U.S. District Judge William H. Walls (N.J.) awarded Zimmer Biomet $13.3 million in attorneys' fees and more than $500,000 in costs after a polymer-patent dispute with Howmedica Osteotonics led to the invalidation of four Howmedica patents, Law360 reports.

Here are three things to know.

1. Judge Walls awarded the fees April 20 and unsealed the order on those figures May 14. The opinion on the fees is not yet public.

2. Howmedica Osteotonics is a Stryker subsidiary.

3. This is not the first patent spat between Zimmer Biomet and Stryker; in 2017, U.S. District Judge Robert Jonker in Grand Rapids, Mich., found in favor of Stryker in a patent infringement case against Zimmer Biomet. He awarded Stryker $248.7 million.

More articles on devices:

22 spine devices receive FDA 510(k) clearance in April 2018

LinkSPINE appoints David Capallo as VP of sales: 3 insights

46% of medical device developers confident they could pass FDA audit & 3 more survey findings

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers